...
首页> 外文期刊>Vaccine >A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses.
【24h】

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses.

机译:接种单剂减毒活SA14-14-2日本脑炎疫苗的儿童的抗体应答的5年随访:免疫原性和记忆消除。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Out of 98 subjects who had participated in the 2000 JE vaccination campaign, 69 people were enrolled in the tests of 2004 and 2005 for the evaluation of long term immune response of a single dose of live attenuated SA14-14-2 JE vaccine. 89.9% of study subjects (62/69) had maintained a high level of neutralizing antibody until 2004 as their GMT was measured as 133 (Min 11, Max 2991). Forty-four subjects were still positive in 2005, 5 years after JE vaccination, and their neutralizing antibody positive rate was significantly higher than that of 69 age-sex matched unvaccinated control subjects: 63.8% (44/69) vs. 14.5% (10/69) (P<0.05). Twenty-four subjects (Group 1) who were seronegative for neutralizing antibody at the 2005 test were given a second dose for revaccination in 2006. Also 49 seronegative (Group 2) subjects who were enrolled as a control group in 2005 were given one dose of primary JE vaccine in 2006. Seven days after vaccination, seropositive rate was discovered to be 76.5% (13/17) and 168.52 (Min 38, Max 2173) in Group 1, while no seroconversion in Group 2. On the 30th day, seropositive rate and GMT were 82.4% (14/17) and 392.01 (Min 22, Max 2197) in Group 1, while 75.7% (28/37) and 45.72 (Min 12, Max 505) in Group 2, respectively. We observed the persistence of neutralizing antibody of single dose of live attenuated SA14-14-2 JE vaccine, 89.9% after 4 years and 63.8% after 5 years, and a rapid secondary immune response on the seventh day after booster dose among those who had been seronegative in spite of the first dose of vaccine. Single dose of live JE vaccine could be effective to provide a long-term protection in JE endemic area, where natural boosting is quite probable in the vaccinees. However, further studies should be carried out to support whether one dose of live JE vaccine is sufficient for people in JE non-endemic area.
机译:在参加2000年JE疫苗接种运动的98位受试者中,有69人参加了2004年和2005年的测试,以评估单剂减毒活SA14-14-2 JE疫苗的长期免疫应答。 89.9%的研究对象(62/69)保持高水平的中和抗体,直到2004年为止,因为他们的GMT为133(最小11,最大2991)。在JE疫苗接种5年后的2005年,有44名受试者仍为阳性,其中和抗体阳性率显着高于69位年龄性别匹配的未接种对照受试者:63.8%(44/69)对14.5%(10 / 69)(P <0.05)。在2005年的测试中对血清中和抗体呈阴性反应的24位受试者(第1组)在2006年接受了第二次疫苗接种。在2005年作为对照组的49位血清阴性(第2组)受试者也给予了1剂在2006年接种了JE疫苗。接种后7天,第1组的血清阳性率为76.5%(13/17)和168.52(Min 38,Max 2173),而第2组没有血清转化。在第30天,血清阳性组1的比率和GMT分别为82.4%(14/17)和392.01(最小22,最大2197),而组2分别为75.7%(28/37)和45.72(最小12,最大505)。我们观察到单剂减毒活SA14-14-2 JE疫苗的中和抗体的持久性,在4年后分别为89.9%和5年后为63.8%,在加强剂量后第7天有快速的继发免疫反应。尽管接种了第一剂疫苗,但仍呈血清阴性。单剂活乙脑疫苗可以有效地在乙脑流行区提供长期保护,因为乙脑流行区很可能会自然加强免疫。但是,应进行进一步的研究以支持一剂活乙脑疫苗是否足以满足乙脑非流行地区的人们。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号